CR Group L.P.
CIK 0001702352 Name as filed on the most recent filing
Filed as CR Group L.P. (9)· Capital Royalty L.P. (2)
46 transaction lines · from 11 filings · filed 2017-03-30 to 2023-09-29 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
- ISSUER T2 Biosystems, Inc. 7 filings
- ISSUER Assertio Holdings, Inc. 2 filings
- ISSUER Valeritas Holdings Inc. 2 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
0 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2023-09-28 |
T2 Biosystems, Inc. TTOO |
S, Open-market sale | 2,858,980 disposed | 0.16 | 450,289.35 | Form 4, filing 0001209191-23-050864 | |
| 2023-09-28 |
T2 Biosystems, Inc. TTOO |
S, Open-market sale | 1,937,852 disposed | 0.16 | 305,211.69 | Form 4, filing 0001209191-23-050864 | |
| 2023-09-28 |
T2 Biosystems, Inc. TTOO |
S, Open-market sale | 1,780,317 disposed | 0.16 | 280,399.93 | Form 4, filing 0001209191-23-050864 | |
| 2023-09-28 |
T2 Biosystems, Inc. TTOO |
S, Open-market sale | 571,796 disposed | 0.16 | 90,057.87 | Form 4, filing 0001209191-23-050864 | |
| 2023-09-27 |
T2 Biosystems, Inc. TTOO |
S, Open-market sale | 2,391,981 disposed | 0.19 | 458,303.56 | Form 4, filing 0001209191-23-050864 | |
| 2023-09-27 |
T2 Biosystems, Inc. TTOO |
S, Open-market sale | 1,621,313 disposed | 0.19 | 310,643.57 | Form 4, filing 0001209191-23-050864 | |
| 2023-09-27 |
T2 Biosystems, Inc. TTOO |
S, Open-market sale | 1,489,512 disposed | 0.19 | 285,390.50 | Form 4, filing 0001209191-23-050864 | |
| 2023-09-27 |
T2 Biosystems, Inc. TTOO |
S, Open-market sale | 478,396 disposed | 0.19 | 91,660.67 | Form 4, filing 0001209191-23-050864 | |
| 2023-09-26 |
T2 Biosystems, Inc. TTOO |
S, Open-market sale | 2,156,717 disposed | 0.20 | 432,853.10 | Form 4, filing 0001209191-23-050732 | |
| 2023-09-26 |
T2 Biosystems, Inc. TTOO |
S, Open-market sale | 1,461,849 disposed | 0.20 | 293,393.09 | Form 4, filing 0001209191-23-050732 | |
| 2023-09-26 |
T2 Biosystems, Inc. TTOO |
S, Open-market sale | 1,343,011 disposed | 0.20 | 269,542.31 | Form 4, filing 0001209191-23-050732 | |
| 2023-09-26 |
T2 Biosystems, Inc. TTOO |
S, Open-market sale | 431,343 disposed | 0.20 | 86,570.54 | Form 4, filing 0001209191-23-050732 | |
| 2023-09-25 |
T2 Biosystems, Inc. TTOO |
S, Open-market sale | 99,979 disposed | 0.25 | 24,994.75 | Form 4, filing 0001209191-23-050677 | |
| 2023-09-25 |
T2 Biosystems, Inc. TTOO |
S, Open-market sale | 67,767 disposed | 0.25 | 16,941.75 | Form 4, filing 0001209191-23-050677 | |
| 2023-09-25 |
T2 Biosystems, Inc. TTOO |
S, Open-market sale | 62,258 disposed | 0.25 | 15,564.50 | Form 4, filing 0001209191-23-050677 | |
| 2023-09-25 |
T2 Biosystems, Inc. TTOO |
S, Open-market sale | 19,996 disposed | 0.25 | 4,999.00 | Form 4, filing 0001209191-23-050677 | |
| 2023-09-22 |
T2 Biosystems, Inc. TTOO |
S, Open-market sale | 2,031,313 disposed | 0.26 | 525,703.80 | Form 4, filing 0001209191-23-050592 | |
| 2023-09-22 |
T2 Biosystems, Inc. TTOO |
S, Open-market sale | 1,376,848 disposed | 0.26 | 356,328.26 | Form 4, filing 0001209191-23-050592 | |
| 2023-09-22 |
T2 Biosystems, Inc. TTOO |
S, Open-market sale | 1,264,920 disposed | 0.26 | 327,361.30 | Form 4, filing 0001209191-23-050592 | |
| 2023-09-22 |
T2 Biosystems, Inc. TTOO |
S, Open-market sale | 406,263 disposed | 0.26 | 105,140.86 | Form 4, filing 0001209191-23-050592 | |
| 2023-09-21 |
T2 Biosystems, Inc. TTOO |
S, Open-market sale | 2,534,754 disposed | 0.30 | 761,693.58 | Form 4, filing 0001209191-23-050530 | |
| 2023-09-21 |
T2 Biosystems, Inc. TTOO |
S, Open-market sale | 1,718,087 disposed | 0.30 | 516,285.14 | Form 4, filing 0001209191-23-050530 | |
| 2023-09-21 |
T2 Biosystems, Inc. TTOO |
S, Open-market sale | 1,578,419 disposed | 0.30 | 474,314.91 | Form 4, filing 0001209191-23-050530 | |
| 2023-09-21 |
T2 Biosystems, Inc. TTOO |
S, Open-market sale | 506,951 disposed | 0.30 | 152,338.78 | Form 4, filing 0001209191-23-050530 | |
| 2023-09-20 |
T2 Biosystems, Inc. TTOO |
S, Open-market sale | 3,100,836 disposed | 0.31 | 963,119.66 | Form 4, filing 0001209191-23-050375 | |
| 2023-09-20 |
T2 Biosystems, Inc. TTOO |
S, Open-market sale | 2,101,784 disposed | 0.31 | 652,814.11 | Form 4, filing 0001209191-23-050375 | |
| 2023-09-20 |
T2 Biosystems, Inc. TTOO |
S, Open-market sale | 1,930,923 disposed | 0.31 | 599,744.68 | Form 4, filing 0001209191-23-050375 | |
| 2023-09-20 |
T2 Biosystems, Inc. TTOO |
S, Open-market sale | 620,167 disposed | 0.31 | 192,623.87 | Form 4, filing 0001209191-23-050375 | |
| 2023-09-19 |
T2 Biosystems, Inc. TTOO |
S, Open-market sale | 4,159,717 disposed | 0.37 | 1,522,456.42 | Form 4, filing 0001209191-23-050273 | |
| 2023-09-19 |
T2 Biosystems, Inc. TTOO |
S, Open-market sale | 2,819,506 disposed | 0.37 | 1,031,939.20 | Form 4, filing 0001209191-23-050273 | |
| 2023-09-19 |
T2 Biosystems, Inc. TTOO |
S, Open-market sale | 2,590,300 disposed | 0.37 | 948,049.80 | Form 4, filing 0001209191-23-050273 | |
| 2023-09-19 |
T2 Biosystems, Inc. TTOO |
S, Open-market sale | 831,943 disposed | 0.37 | 304,491.14 | Form 4, filing 0001209191-23-050273 | |
| 2020-12-24 |
Assertio Holdings, Inc. ASRT |
S, Open-market sale | 1,982,851 disposed | 0.37 | 730,085.74 | Form 4, filing 0001209191-20-065421 | |
| 2020-12-23 |
Assertio Holdings, Inc. ASRT |
S, Open-market sale | 6,784,334 disposed | 0.37 | 2,540,733.08 | Form 4, filing 0001209191-20-065421 | |
| 2020-12-22 |
Assertio Holdings, Inc. ASRT |
S, Open-market sale | 1,500,000 disposed | 0.34 | 508,500.00 | Form 4, filing 0001209191-20-064951 | |
| 2020-12-21 |
Assertio Holdings, Inc. ASRT |
S, Open-market sale | 500,000 disposed | 0.36 | 180,100.00 | Form 4, filing 0001209191-20-064951 | |
| 2020-12-18 |
Assertio Holdings, Inc. ASRT |
S, Open-market sale | 500,000 disposed | 0.38 | 188,800.00 | Form 4, filing 0001209191-20-064951 | |
| 2018-11-16 |
Valeritas Holdings Inc. VLRX |
P, Open-market purchase | 7,427,065 acquired | Not reported | Not priced | Form 4, filing 0000899243-18-029509 | |
| 2018-11-16 |
Valeritas Holdings Inc. VLRX |
P, Open-market purchase | 4,224,605 acquired | Not reported | Not priced | Form 4, filing 0000899243-18-029509 | |
| 2018-11-16 |
Valeritas Holdings Inc. VLRX |
P, Open-market purchase | 2,083,333 acquired | Not reported | Not priced | Form 4, filing 0000899243-18-029509 | |
| 2018-11-16 |
Valeritas Holdings Inc. VLRX |
P, Open-market purchase | 1,264,997 acquired | Not reported | Not priced | Form 4, filing 0000899243-18-029509 | |
| 2017-03-28 |
Valeritas Holdings Inc. VLRX |
P, Open-market purchase | 2,116,803 acquired | 10.00 | 21,168,030.00 | Form 4, filing 0001209191-17-023755 | |
| 2017-03-28 |
Valeritas Holdings Inc. VLRX |
P, Open-market purchase | 800,400 acquired | 10.00 | 8,004,000.00 | Form 4, filing 0001209191-17-023755 | |
| 2017-03-28 |
Valeritas Holdings Inc. VLRX |
P, Open-market purchase | 490,234 acquired | 10.00 | 4,902,340.00 | Form 4, filing 0001209191-17-023755 | |
| 2017-03-28 |
Valeritas Holdings Inc. VLRX |
P, Open-market purchase | 437,836 acquired | 10.00 | 4,378,360.00 | Form 4, filing 0001209191-17-023755 | |
| 2017-03-28 |
Valeritas Holdings Inc. VLRX |
P, Open-market purchase | 154,727 acquired | 10.00 | 1,547,270.00 | Form 4, filing 0001209191-17-023755 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
- P, Open-market purchase
- Open-market purchase
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.
How to cite this page
ebomi catalog. CR Group L.P., insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001702352
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6